Standard BioTools Inc. Common Stock (LAB) is a publicly traded Healthcare sector company. As of October 1, 2026, LAB trades at $0.73 with a market cap of $280.03M and a P/E ratio of -3.62. LAB moved -2.27% today. Year to date, LAB is -41.69%; over the trailing twelve months it is -43.03%. Its 52-week range spans $0.63 to $1.72. Rallies surfaces LAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Standard BioTools Inc. Common Stock (LAB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LAB moved -2.27% today.
| Metric | Value |
|---|---|
| Price | $0.73 |
| Market Cap | $280.03M |
| P/E Ratio | -3.62 |
| EPS | $-0.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.72 |
| 52-Week Low | $0.63 |
| Volume | 812.79K |
| Avg Volume | 0 |
| Revenue (TTM) | $85.33M |
| Net Income | $-74.90M |
| Gross Margin | 49.86% |
LAB analyst coverage data. Average price target: $0.00.